Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · IEX Real-Time Price · USD
1.660
+0.020 (1.22%)
At close: Mar 28, 2024, 4:00 PM
1.680
+0.020 (1.20%)
After-hours: Mar 28, 2024, 5:54 PM EDT
Rockwell Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Rockwell Medical stock have an average target of 7.00, with a low estimate of 5.00 and a high estimate of 9.00. The average target predicts an increase of 321.69% from the current stock price of 1.66.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RMTI stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +442.17% | Mar 25, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +562.65% | Nov 15, 2023 |
Maxim Group | Maxim Group | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +201.20% | Oct 5, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +562.65% | Oct 4, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +562.65% | Sep 28, 2023 |
Financial Forecast
Revenue This Year
85.84M
from 72.81M
Increased by 17.89%
Revenue Next Year
99.97M
from 85.84M
Increased by 16.47%
EPS This Year
-0.41
from -1.89
EPS Next Year
-0.13
from -0.41
Revenue Forecast
Revenue | 2023 | 2024 | 2025 |
---|---|---|---|
High | 88.9M | 104.9M | 116.0M |
Avg | 85.8M | 100.0M | 112.7M |
Low | 81.9M | 94.2M | 108.3M |
Revenue Growth
Revenue Growth | 2023 | 2024 | 2025 |
---|---|---|---|
High | 22.1% | 22.2% | 16.1% |
Avg | 17.9% | 16.5% | 12.8% |
Low | 12.5% | 9.7% | 8.3% |
EPS Forecast
EPS | 2023 | 2024 | 2025 |
---|---|---|---|
High | -0.42 | -0.12 | 0.05 |
Avg | -0.41 | -0.13 | 0.05 |
Low | -0.39 | -0.14 | 0.05 |
EPS Growth
EPS Growth | 2023 | 2024 | 2025 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.